ABL-302

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameABL-302

Drug Alias NameABL302

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbl Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbl Bio Inc

Active IndicationsN/A

Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A